Skip to content

The "make-or-break" key for the timing of strengthening kidney and stabilizing fetus: focusing on the spatiotemporal effect of lipid metabolism reprogramming-mediated polarization of decidual macrophages

The "make-or-break" key for the timing of strengthening kidney and stabilizing fetus: focusing on the spatiotemporal effect of lipid metabolism reprogramming-mediated polarization of decidual macrophages

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ITMCTR
Registry ID
ITMCTR2025001852
Enrollment
Unknown
Registered
2025-09-26
Start date
2025-10-15
Completion date
Unknown
Last updated
2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Recurrent spontaneous abortion

Interventions

The group for strengthening the kidney and stabilizing the fetus:Dydrogesterone tablets 10mg each time, twice a day
Traditional Chinese medicine for strengthening the kidney and stabilizing the fetus, take 150ml each time, three times a day
Western Medicine treatment group:Dydrogesterone tablets 10mg each time, twice a day
Healthy Pregnancy Group:No intervention was carried out
only relevant clinical data collection was conducted

Sponsors

Affiliated Hospital of Chengdu University of TCM
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
22 Years to 49 Years

Inclusion criteria

Inclusion criteria: (1) Meeting the diagnostic criteria of Western medicine and the syndrome differentiation standards of Traditional Chinese Medicine; (2) Having experienced two or more spontaneous abortions; (3) Gestational age less than 12 weeks; (4) No abnormal semen in the husband; (5) No chromosomal abnormalities in both the husband and wife; (6) No anatomical structural abnormalities; (7) No autoimmune diseases; (8) No endocrine disorders; (9) No infectious factors; (10) No abnormalities in blood coagulation analysis; (11) The subjects have given informed consent and voluntarily signed the informed consent form.

Exclusion criteria

Exclusion criteria: (1) Genital tract malformations; (2) Acute or chronic infection period; (3) Abnormal semen in the male partner; (4) Autoimmune diseases; (5) Recent use of immunosuppressants; (6) Coexisting diabetes, hypertension, heart disease, liver and kidney diseases, and blood disorders; (7) History of smoking and excessive drinking; (8) Vaccination within the last three months; (9) Failure to take medication as prescribed, making it impossible to assess the therapeutic effect, or incomplete data affecting the assessment of the therapeutic effect.

Design outcomes

Primary

MeasureTime frame
clinical signs and symptoms;Metabolomics;

Secondary

MeasureTime frame
The insertion time for stabilizing the fetus;Gynecological examination;Gynecological color Doppler ultrasound examination;Estrogen;Progesterone;Human chorionic gonadotropin;

Countries

China

Contacts

Public ContactLinwen Deng

Affiliated Hospital of Chengdu University of TCM

dlwen1982@163.com15308078860

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026